Occupational allergy to bumblebees:: Allergens of Bombus terrestris

被引:38
作者
Hoffman, DR [1 ]
El-Choufani, SE
Smith, MM
de Groot, H
机构
[1] E Carolina Univ, Brody Sch Med, Dept Pathol & Lab Med, Greenville, NC 27858 USA
[2] Univ Rotterdam Hosp, Dept Allergol, Rotterdam, Netherlands
关键词
bumblebee; venom; phospholipase; protease; occupational allergy; epitope; honeybee;
D O I
10.1067/mai.2001.119029
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: With the increase in commercial vegetable production in greenhouses, occupational sensitization to bumble-bee venom is becoming more common. Studies using sera from subjects thus sensitized allow evaluation of the allergenic specificity of bumblebee sensitization. Objective: The purposes of this study were to determine the degree of species group specificity of bumblebee venom allergens in sera of allergic patients and to investigate the structural basis of this specificity. Methods: Allergens were purified from bumblebee venom, studied serologically by direct binding and inhibition techniques, and characterized by enzyme analysis and amino acid sequencing. Three-dimensional models of the phospholipases were constructed and analyzed. Results: Bombus terrestris venom contains phospholipase A(2), venom protease, hyaluronidase, and acid phosphatase allergens. The protease and phospholipase A(2) allergens contain IgE-reactive epitopes that are different from those seen in Bombus pennsylvanicus, a North American species. Bumblebee phospholipase A(2) is only 53% identical to honeybee phospholipase A(2),. The results of 3-dimensional modeling are consistent with the immunologic observations. Conclusions: Patients with primary bumblebee sensitization should be diagnosed and treated with venom from the appropriate species group of bumblebees. Bumblebee venom phospholipase A(2) and protease are antigenically distinct from honeybee venom proteins. There are significant species group-specific epitopes on bumblebee venom proteins.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 17 条
[1]   Allergy to bumblebee venom. III. Immunotherapy follow-up study (safety and efficacy) in patients with occupational bumblebee-venom anaphylaxis [J].
de Jong, NW ;
Vermeulen, AM ;
de Groot, H .
ALLERGY, 1999, 54 (09) :980-984
[2]  
DEGROOT H, 1995, ALLERGY, V50, P581, DOI 10.1111/j.1398-9995.1995.tb01203.x
[3]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[4]   ALLERGENS IN HYMENOPTERA VENOM .25. THE AMINO-ACID-SEQUENCES OF ANTIGEN 5 MOLECULES AND THE STRUCTURAL BASIS OF ANTIGENIC CROSS-REACTIVITY [J].
HOFFMAN, DR .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 92 (05) :707-716
[5]  
HOFFMAN DR, 1981, ANN ALLERGY, V46, P304
[6]   Allergens in hymenoptera venom .27. Bumblebee venom allergy and allergens [J].
Hoffman, DR ;
Jacobson, RS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (03) :812-821
[7]  
HOFFMAN DR, 1979, ANN ALLERGY, V42, P224
[8]  
JACOBSON RS, 1992, J ALLERGY CLIN IMMUN, V89, P292
[9]   Structure and biology of stinging insect venom allergens [J].
King, TP ;
Spangfort, MD .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 123 (02) :99-106
[10]   OCCUPATIONAL ALLERGY TO BUMBLE BEE VENOM [J].
KOCHUYT, AM ;
VANHOEYVELD, E ;
STEVENS, EAM .
CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (03) :190-195